These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23750388)

  • 1. [Key aspects regarding HIV and travel].
    Gardiol C; Cavassini M
    Rev Med Suisse; 2013 May; 9(385):963-7. PubMed ID: 23750388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection and travel: pretravel recommendations and health-related risks.
    Franco-Paredes C; Hidron A; Tellez I; Lesesne J; Del Rio C
    Top HIV Med; 2009; 17(1):2-11. PubMed ID: 19270343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical management of acute and chronic human immunodeficiency virus infection before starting antiretroviral treatment].
    Miró JM; Manzardo C; Zamora L; Pumarola T; Herreras Z; Gallart T; Gatell JM
    Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):759-72. PubMed ID: 22078726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Travel patterns and health risks for patients infected with HIV.
    Sherrard AW; McCarthy AE
    Travel Med Infect Dis; 2009 Sep; 7(5):291-5. PubMed ID: 19747664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Travel medicine for HIV-infected patients].
    Rossi M; Furrer H
    Ther Umsch; 2001 Jun; 58(6):381-6. PubMed ID: 11441700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV and travel].
    D'Acremont V; Cavassini ML; Tarr PE; Genton B
    Rev Med Suisse; 2005 May; 1(19):1268-74. PubMed ID: 15962624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human immunodeficiency virus-infected traveler.
    Castelli F; Patroni A
    Clin Infect Dis; 2000 Dec; 31(6):1403-8. PubMed ID: 11096010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-retroviral therapy among HIV infected travelers to Hajj pilgrimage.
    Habib AG; Abdulmumini M; Dalhat MM; Hamza M; Iliyasu G
    J Travel Med; 2010; 17(3):176-81. PubMed ID: 20536886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The HIV-infected traveler: infectious risks and prevention].
    Couzigou C; Taburet AM; Voyer C; Bourée P; Vittecoq D
    Presse Med; 2008 Mar; 37(3 Pt 2):490-9. PubMed ID: 18036772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.
    Campbell JD; Moore D; Degerman R; Kaharuza F; Were W; Muramuzi E; Odongo G; Wetaka M; Mermin J; Tappero JW
    Clin Infect Dis; 2012 Apr; 54(8):1204-11. PubMed ID: 22423133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-travel preparation and outcome of HIV-infected travellers from a UK clinic.
    Cathcart S; Boyle J; Sabin C; Johnson M; Zuckerman JN
    Travel Med Infect Dis; 2003 May; 1(2):114-8. PubMed ID: 17291897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
    Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
    Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HIV-positive traveler.
    Bhadelia N; Klotman M; Caplivski D
    Am J Med; 2007 Jul; 120(7):574-80. PubMed ID: 17602926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of infection in immunocompromised travelers].
    Zbinden D; D'Acremont V; Manuel O
    Rev Med Suisse; 2013 May; 9(385):958-62. PubMed ID: 23750387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What advice should be given to prevent HIV infection when travelling abroad?].
    Hasle G
    Tidsskr Nor Laegeforen; 1994 Jun; 114(15):1718-9. PubMed ID: 8079285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.
    Miro JM; Lopez JC; Podzamczer D; Peña JM; Alberdi JC; Martínez E; Domingo P; Cosin J; Claramonte X; Arribas JR; Santín M; Ribera E;
    Clin Infect Dis; 2006 Jul; 43(1):79-89. PubMed ID: 16758422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.
    Buchacz K; Baker RK; Palella FJ; Shaw L; Patel P; Lichtenstein KA; Chmiel JS; Vellozzi C; Debes R; Henry K; Overton ET; Bush TJ; Tedaldi E; Carpenter C; Mayer KH; Brooks JT;
    Antivir Ther; 2013; 18(1):65-75. PubMed ID: 23111762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.